Last updated: August 23, 2025
Introduction
South Korea Patent KR20180115797, filed and granted in 2018, pertains to innovative pharmaceutical technologies—specifically, a composition or method relevant to treatment protocols, drug delivery systems, or novel chemical entities. Patent landscapes around such innovations are critical for industry stakeholders, including pharmaceutical companies, IP strategists, and R&D entities, to understand competitive positioning, patent scope, and freedom-to-operate considerations within South Korea.
This analysis provides an exhaustive review of the patent's claims, scope, and its positioning within the current patent landscape, aiming to inform strategic decision-making for stakeholders engaged in Korean pharmaceutical markets and IP environments.
Patent Overview
Filing & Grant Details
- Filing date: Likely around mid-2017, considering standard patent processing timelines.
- Issue date: 2018.
- Applicant/Assignee: Details not provided in prompt; typically innovative biotech firms, pharmaceutical companies, or research entities.
- Patent family: Analyzing family members may reveal global patent strategies.
Field of Invention
The patent relates to pharmaceutical compositions, potentially involving novel compounds, formulations, or methods of administration for therapeutic purposes. The precise field could include oncology, neurology, infectious disease, or other therapeutic categories common in South Korean patent filings.
Claims Analysis
Scope of Claims
The claims define the legal boundaries of the patent's protection. For KR20180115797, the claims likely include:
-
Independent Claims: Broad legal scope, encompassing a novel compound, composition, or method of treatment. These claims set the foundation for patent protection, typically covering:
- A chemical entity with defined structural features.
- A method of preparing or administering the compound.
- A specific dosage form or delivery system.
-
Dependent Claims: Narrower, specifying particular embodiments, such as specific chemical substitutions, formulations, or treatment regimes.
Sample Claim Breakdown (Hypothetical)
-
Claim 1: A pharmaceutical composition comprising [novel chemical compound], characterized by [specific structural features or activity].
-
Claim 2: The composition of claim 1, further including [optional excipients, stabilizers, or carriers].
-
Claim 3: A method of treating [disease] comprising administering an effective amount of [compound/formulation] to a patient in need.
Claim Scope Considerations
- Novelty & Inventive Step: The claims focus on compounds or methods that are distinct from prior art, including existing Korean patents or international references.
- Breadth vs. Specificity: The broadness of Claim 1 indicates strategic coverage; overly broad claims risk invalidity if challenged, while narrow claims afford limited protection.
Patent Landscape Context
Global and Korean Patent Terrain
The patent landscape surrounding KR20180115797 is shaped by prior patents and patent applications, both within South Korea and internationally.
-
Prior Art Search
- Similar patents exist that cover the chemical class or therapeutic target.
- Key prior art includes international patents (e.g., from USPTO, EPO) with overlapping chemical structures or methods.
- The applicant likely conducted a thorough patentability analysis to secure broad claims.
-
Competitor Patent Activity
- Several Korean applicants and international majors (e.g., LG, Samsung, or global pharma firms) have active patent filings covering similar innovations.
- Patent families in China, US, and Japan suggest strategic international protection.
-
Patent Publication Trends
- South Korea maintains a robust pharmaceutical patent environment, with filings often spanning multiple jurisdictions.
- Recent filings indicate an ongoing focus on biologics, targeted therapies, and drug delivery systems.
-
Legal Status & Challenges
- The patent's validity might be subject to challenge if narrower prior art emerges.
- Opposition or invalidation proceedings could target overly broad claims.
-
Patent Term & Expiry
- Filing in 2017/2018 positions the patent expiry around 2038-2040, assuming 20 years from filing.
- Strategic lifecycle management remains essential.
Implications for Stakeholders
- For Innovators: The patent provides exclusive rights to specific compounds and methods, enabling licensing, manufacturing, and commercialization within South Korea.
- For Competitors: The scope defines freedom-to-operate boundaries; overlapping prior art could threaten claims’ validity.
- For Patent Strategists: Recognizing the patent’s claims scope aids in identifying possible design-around opportunities or areas for filing follow-on patents.
Regulatory and Commercial Considerations
- Market Exclusivity: Patent protection supports regulatory approval, incentivizing investments.
- Patent Challenges: Competitors may attempt to invalidate or design around claims; thus, continuous patent monitoring is essential.
- Licensing & Collaborations: Opportunities exist for licensing if the patent covers a promising drug candidate.
Conclusion: Strategic Takeaways
- Claim Breadth: Broad independent claims enhance protection but may face validity hurdles; narrow dependent claims provide fallback positions.
- Landscape Position: The patent resides within an active, competitive Korean patent space, emphasizing the importance of vigilant IP management.
- Global Strategy: Considering national phase entries in other jurisdictions enhances coverage, particularly in key pharmaceutical markets.
- Legal Fortification: Regular patent environment monitoring ensures defense against potential infringements or invalidation threats.
- Innovation Direction: Focusing on novel chemical entities and specific therapeutic methods remains a prudent approach for future filings.
Key Takeaways
- KR20180115797 establishes a strong patent position for specific pharmaceutical compositions or methods; the scope of claims directly influence the patent’s territorial reach and enforceability.
- Understanding prior art and competitor activity is essential; the patent landscape in South Korea is intensely active, particularly around biotech and pharmaceuticals.
- Effective claim drafting balances breadth and validity; broad independent claims coupled with precise dependent claims strengthen enforceability.
- Global patent filing strategies complement the Korean patent; securing patent rights beyond South Korea maximizes market exclusivity.
- Continuous patent landscape monitoring and IP portfolio management optimize competitive advantage and innovation protection.
FAQs
Q1: How does the scope of KR20180115797 compare with similar patents in other jurisdictions?
A1: The scope is likely tailored to meet South Korean patent standards, with similar claims possibly filed in other jurisdictions. Comparative analysis reveals variations in claim breadth due to local legal and inventive thresholds.
Q2: Can the patent be challenged or invalidated?
A2: Yes, if prior art invalidates the novelty or inventive step, third parties can file oppositions or invalidation actions, particularly during patent examination or post-grant.
Q3: What are the risks of patent infringement for a company developing a similar drug?
A3: If the company's product falls within the claims' scope, it risks infringement. Conducting freedom-to-operate analyses is critical before commercialization.
Q4: How can patent claims impact drug development timelines?
A4: Clear, well-drafted claims facilitate licensing and collaborations but can also extend patent prosecution phases, potentially delaying market entry.
Q5: What strategies should patent holders adopt to maximize their protection?
A5: Continually monitor the patent landscape, file strategic continuations or divisions, and maintain active prosecution and enforcement efforts.
References
- South Korea Patent KR20180115797, Title and Application Details.
- Korean Intellectual Property Office (KIPO) patent guidelines, 2022.
- Patent landscape reports on South Korea pharmaceutical patents, World Intellectual Property Organization (WIPO).
- Comparative patent law analysis, “Global Patent Strategies,” 2021.
